LobbyingIxpressgenes lobbying by quarter
Ixpressgenes's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q2 2025; the issues it reports most are Budget/Appropriations and Medical/Disease Research/Clinical Labs.
Ixpressgenes
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $60K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $10K | 1 |
| Q3 2025 | $20K | 1 |
| Q4 2025 | $20K | 1 |
| Q1 2026 | $20K | 1 |
| Q2 2026 | $20K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$30K · 5 reports
- Medical research and clinical labs$30K · 5 reports
- Veterans$30K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
Firms it paid
| Firm | ||
|---|---|---|
| Williams and Jensen, PLLC | $90K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JORDAN MILLS | Regional Director, Senator Tuberville | Q2 2026 |
| MAHLET MAKONNEN | Department of Veterans Affairs, Attorney Advisor | Q2 2026 |
| ROBERT BUTORA | Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Williams and Jensen, PLLC | $20K |
| 04/17for Q1 | Williams and Jensen, PLLC | $20K |
| 01/20for Q4 2025 | Williams and Jensen, PLLC | $20K |
| 25/10/17for Q3 2025 | Williams and Jensen, PLLC | $20K |
| 25/07/18for Q2 2025 | Williams and Jensen, PLLC | $10K |
| 25/07/09for Q2 2025 | Williams and Jensen, PLLC | Under $5,000 |